{"disease":{"id":"crc-colorectal-cancer","name":"crc colorectal cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07066046","title":"Artificial Intelligence-assisted Colonoscopy in the Detection and Characterization of Colorectal Lesions","phase":"NA","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Instituto do Cancer do Estado de São Paulo","has_results":false},{"nct_id":"NCT07284849","title":"A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"Incyte Corporation","has_results":false},{"nct_id":"NCT07224815","title":"cfDNA 5mC/5hmC Biomarkers to Predict Chemotherapy Response in Metastatic Colorectal Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT06192862","title":"Effectiveness of Using Mobile Health Technology in Colorectal Cancer Screening Uptake","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT07224841","title":"Development of a cfDNA 5mC/5hmC-based Biomarker Panel to Predict Targeted Therapy Efficacy in mCRC","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT07033156","title":"An Exploratory Study on Gene Methylation Detection of Colorectal Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Zhejiang Provincial People's Hospital","has_results":false},{"nct_id":"NCT07198321","title":"A Single-Arm, Open-Label, Multicenter Phase I/II Clinical Study of GFH276 in Patients With RAS-Mutant Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":450,"lead_sponsor_name":"Genfleet Therapeutics (Shanghai) Inc.","has_results":false},{"nct_id":"NCT06734156","title":"CARE-CRC: Microbiome Insights and Correlations for Risk and Outcomes in Colorectal Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Gulbenkian Institute for Molecular Medicine","has_results":false},{"nct_id":"NCT06612281","title":"Evaluation of Gixam's Performance in a FIT Negative Population","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Jubaan Ltd.","has_results":false},{"nct_id":"NCT06261008","title":"Interactive Telehealth Intervention to Increase Longitudinal Adherence to Repeat Faecal Immunochemical Test Screening","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":370,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT07286695","title":"Fruquintinib Combined With Trifluridine/Tipiracil Versus Bevacizumab Combined With Trifluridine/Tipiracil for Advanced Metastatic Colorectal Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":292,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT06957015","title":"A Prospective Study to Evaluate the Performance of a Real-time System in the Estimation of Colorectal Polyp Size","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":278,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT06849362","title":"Multicenter Retrospective Study on Optimizing Combination Immunotherapy Strategies in MSS/MSI-L/pMMR Advanced Colorectal Cancer","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":200,"lead_sponsor_name":"Yue Gou","has_results":false},{"nct_id":"NCT07376707","title":"A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":194,"lead_sponsor_name":"Hefei TG ImmunoPharma Co., Ltd.","has_results":false},{"nct_id":"NCT06879886","title":"MRD-Guided Surveillance in Resectable Stage IV Metastatic Colorectal Cancer (SURVEILLANCE-II)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":181,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT07497789","title":"SMYD3-Driven Metabolic Rewiring in Colorectal Liver Metastases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":156,"lead_sponsor_name":"Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis","has_results":false},{"nct_id":"NCT07254910","title":"Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"University of Oklahoma","has_results":false},{"nct_id":"NCT06720987","title":"A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":128,"lead_sponsor_name":"Kumquat Biosciences Inc.","has_results":false},{"nct_id":"NCT07405736","title":"Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":124,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT05651022","title":"Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Indaptus Therapeutics, Inc","has_results":false},{"nct_id":"NCT03597581","title":"A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":89,"lead_sponsor_name":"Inspirna, Inc.","has_results":false},{"nct_id":"NCT05286814","title":"PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT07153458","title":"Identification of New Non-invasive, Predictive, and Diagnostic Biomarkers for Colorectal Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis","has_results":false},{"nct_id":"NCT07446322","title":"FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Oncolytics Biotech","has_results":false},{"nct_id":"NCT07478731","title":"Neoadjuvant SHR-1701 Plus Chemoradiotherapy for Locally Advanced Rectal Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Hong Qiu","has_results":false},{"nct_id":"NCT06985316","title":"An Exploratory Clinical Study Evaluating the Efficacy and Safety of Tunlametinib Combined With Fruquintinib in the Third-line Treatment of Advanced Colorectal Cancer Patients With RAS Mutations.","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":34,"lead_sponsor_name":"Liu Huang","has_results":false},{"nct_id":"NCT06653010","title":"Universal CAR-T Cells (REVO-UWD-01) for Metastatic Colorectal Cancer","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Wondercel Biotech (ShenZhen)","has_results":false},{"nct_id":"NCT06675513","title":"Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Wondercel Biotech (ShenZhen)","has_results":false},{"nct_id":"NCT06640166","title":"Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT07009145","title":"QL1706 Plus Bevacizumab for Unresectable or Metastatic MSI-H/dMMR CRC","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":22,"lead_sponsor_name":"Qianfoshan Hospital","has_results":false},{"nct_id":"NCT05631574","title":"Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":13,"lead_sponsor_name":"Biomea Fusion Inc.","has_results":false},{"nct_id":"NCT07504484","title":"Safety and Efficacy of Neoantigen-Based Personalized Immunotherapy as Consolidation Therapy After Standard Adjuvant Treatment in Resectable Stage III Colorectal Cancer or Non-Small Cell Lung Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Ying Yuan, MD","has_results":false}],"total":32},"guidelines":[],"source":"Drug Landscape verified database"}